Methixene is a synthetic anticholinergic compound that has been associated with pharmacological applications involving the central and peripheral nervous systems. It belongs to the class of antimuscarinic agents and has historically been investigated and used for its effects on cholinergic neurotransmission.
Methixene works primarily by reducing the effects of acetylcholine at muscarinic receptors, producing anticholinergic activity. It has been associated with pharmaceutical applications in neurological disorders, particularly conditions involving abnormal muscle movement.
Methixene is a synthetic small-molecule compound with the molecular formula C20H25NS and a molecular weight of approximately 311.49 g/mol. Its CAS Number is 496-78-6.
Methixene is a thioxanthene-related anticholinergic compound and is generally supplied for qualified pharmaceutical, analytical and research applications.
Methixene exerts its pharmacological activity primarily through antimuscarinic effects, reducing acetylcholine-mediated cholinergic signaling.
By inhibiting muscarinic receptor activity, methixene can influence cholinergic pathways involved in smooth-muscle activity, secretory functions and neurological signaling.
Methixene has been associated with pharmaceutical and pharmacological applications involving:
The availability and approved indications of methixene may differ between countries and regulatory jurisdictions.
Methixene API can be evaluated using validated analytical procedures for identification, assay, related substances, water content, residue on ignition, residual solvents and elemental impurities, as applicable.
Chromatographic and spectroscopic techniques may be used for identity, assay and impurity profiling. Final acceptance criteria should be based on the manufacturer's validated drug-substance specification and current Certificate of Analysis.
Methixene should be stored in a tightly closed pharmaceutical-grade container under controlled conditions and protected from excessive moisture, heat and direct light.
Specific storage requirements should follow the manufacturer's approved specification.
Methixene API may be supplied for qualified pharmaceutical manufacturing, formulation development, analytical testing and research applications, subject to applicable quality and regulatory requirements.
Methixene is a specialized anticholinergic API associated with neurological and muscarinic receptor pharmacology. Product specifications, Certificate of Analysis, analytical documentation, packaging information and commercial details can be provided according to applicable requirements.
| Parameter | Specification |
|---|---|
| Appearance | White crystalline powder or crystals |
| Identification | IR & HPLC compliant |
| Assay (HPLC) | 98.0% – 102.0% |
| Loss on Drying | NMT 1.0% |
| Residue on Ignition | NMT 0.5% |
| Individual Impurity | NMT 0.5% |
| Total Impurities | NMT 1.0% |
| Water Content | NMT 1.0% |
| Melting Point | Approximately 105–110 °C |